- Axial Biotherapeutics Presents New Preclinical Data from AB-2004 Program Demonstrating Reduction of Microbiome-Derived Metabolites in Mouse Models with Autism Spectrum Disorder at the International Society for Autism Research (INSAR) 2019 Annual Meeting Global Banking And Finance Review
- Autism Diagnosis Reliable in Young Toddlers Medscape
- Experimental Autism Drugs Aim to Improve Social Communication Skills Scientific American
- View full coverage on Google News
Axial Biotherapeutics Presents New Preclinical Data from AB-2004 Program Demonstrating Reduction of Microbiome-Derived Metabolites in Mouse Models with Autism Spectrum Disorder at the International Society for Autism Research (INSAR) 2019 Annual Meeting – Global Banking And Finance Review
ByGoogle News
May 3, 2019